Advanced Search

 

Study ID Status Title Patient Level Data
201929 Recruiting Efficacy of ropinirole controlled-release on the motor symptoms in advanced Parkinson’s disease patients: A post-hoc analysis of Japanese phase III clinical trial (Study ID: 201929)
201934 Recruiting An investigation of drug concentrations in hair and sweat of subjects with respiratory diseases following the exposure of inhaled chronic respiratory therapies as a future means of assessing treatment related compliance
201935 Recruiting Etude des conditions d'utilisation et du profil de securite de'allli OR Study of the conditions of use and safety profile of Alli
201955 Completed Incidence of Gall Bladder Related Events Among Type 2 Diabetes Patients
201958 Completed An open label, six-period cross-over, single and repeat dose study to determine the pharmacokinetics of fluticasone furoate and GSK961081 when administered alone, in combination, or concurrently via the ELLIPTA
201959 Completed A Phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and above
201986 Completed PGx7611: Genetic Investigation of ALT elevations in Eltrombopag studies in ITP subjects
202 Completed A Single-Dose Bioequivalence/Effect of Food Evaluation of WELLBUTRIN® Sustained-Release
202012 PRJ2429: Effect of inhaled corticosteroid (ICS) particle size on asthma efficacy and safety outcomes: A systematic literature review and meta-analysis
202026 Not yet recruiting LAMICTAL Special Drug Use Investigation(mono-therapy for Typical Absence Seizure)
202029 Recruiting ZAGALLO Capsules Drug Use Investigation
202050 Completed PGx7607: PGx evaluation of pyrexia by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK115306 and MEK116513
202051 Completed PGX7608: PGx evaluation of efficacy of dabrafenib and trametinib by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK114267, MEK115306 and MEK116513
202055 Completed European Medicines Agency (EMA) post-authorisation safety study of influenza vaccine
202063 Completed Additional subgroup analysis of onabotulinumtoxinA phase III trial in post-stroke patients with upper limb spasticity
202065 Completed Meta-Analysis Plan for an exploratory analysis of a composite endpoint for deterioration to compare the efficacy of Umeclidinium/Vilanterol Inhalation Powder 62.5/25 mcg with tiotropium 18mcg in subjects with Chronic Obstructive Pulmonary Disease (COPD)
202066 Completed Meta-Analysis Plan for an analysis to compare the efficacy of Umeclidinium/Vilanterol Inhalation Powder 62.5/25 mcg with tiotropium 18mcg in subjects with Chronic Obstructive Pulmonary Disease (COPD)
202067 Completed Meta-Analysis Plan for an analysis to compare the addition of Umeclidinium Inhalation Powder 62.5mcg to ICS/LABA with Placebo plus ICS/LABA in subjects with Chronic Obstructive Pulmonary Disease (COPD).
202089 Completed Predictive effect of eosinophil counts on bronchodilator response in COPD
202093 Completed A Phase 2a Study to Evaluate the Pharmacokinetic, Safety, Tolerability and Clinical Effect of Topically Applied Umeclidinium/GSK573719 in Subjects with Primary Axillary Hyperhidrosis
202115 Completed Can social listening data be used to provide meaningful insights into potential abuse of bupropion?
202121 Completed PGx7635: Meta-analysis of data from FCGR PGx evaluations of ofatumumab DLBCL studies
202122 Completed PGx7597: Meta-analyses of data from FCGR PGx evaluations of ofatumumab CLL studies
202146 Not yet recruiting HO-15-15509 - Adelphi survey Benlysta effectiveness
202161 Completed A clinical study investigating the efficacy of a dentifrice in providing immediate and short term relief from dentinal hypersensitivity.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.